Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

November 30, 2008

Conditions
Parenteral Nutrition
Interventions
DRUG

SMOF lipid and Intralipid

1-2 g, 5-7 days, 28 days

Trial Locations (12)

2065

North Shore Private Hospital, Saint Leonards

3168

Monash Medical Centre, Melbourne

69437

Hopital Edouard Herriot, Unite de Nutrition a Domicile Lyon, Lyon

92110

Hopital Beaujon, Clichy

0 9000

Aalborg University Hospital, Department of Medical Gastroenterology, Aalborg

0 2100

Rigshospitalet, Department of Medical Gastroenterology, Copenhagen

0 45100

"Beilinson Medical Center, Department of Surgery B", Petah Tikva

6500 HB

University Medical Center, Nijmegen

31-501

Wydzial Lekarski I Katedra Chirurgii Ogolnej, Krakow

00-416

Samodzielny Publiczny Szpital Kliniczny im. Prof. W. Orłowskiego, Warsaw

0M6 8HD

Hope Hospital, Manchester

NG7 2UH

University Hospital, Queen's Medical Centre, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Fresenius Kabi

INDUSTRY